MicroRNA-669f-5p targeting deoxycytidinephosphate deaminase contributes to sevoflurane-induced cognitive impairments

Yuanping Zhong1, Chao Zhang1, Yuan Li2

  • 1Department of Anesthesiology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, Guizhou 563003, PR China.

PubMed
Abstract

Insights

MicroRNA-669f-5p exacerbates sevoflurane-induced cognitive impairment in aged mice by targeting Dctd. Inhibiting this microRNA and targeting the TLR2/4-MyD88-NF-κB pathway may offer therapeutic strategies for postoperative cognitive dysfunction.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Anesthesiology

Background:

  • Postoperative cognitive dysfunction (POCD) is a frequent complication in elderly patients after sevoflurane anesthesia.
  • MicroRNAs are implicated in sevoflurane-induced cognitive deficits, but the specific role of microRNA (miR)-669f-5p is not well understood.

Purpose of the Study:

  • To investigate the role and mechanism of miR-669f-5p in sevoflurane-induced cognitive impairment in aged mice.
  • To identify potential therapeutic targets for preventing POCD.

Main Methods:

  • Aged mice and hippocampal neurons were exposed to sevoflurane, with cognitive function assessed via the Morris water maze test.
  • Neuroapoptosis, cellular proliferation, and molecular mechanisms involving miR-669f-5p, Dctd, and the TLR2/4-MyD88-NF-κB pathway were analyzed using various molecular and cellular assays.

Main Results:

  • Upregulation of miR-669f-5p was observed in the hippocampus of mice with POCD.
  • Inhibition of miR-669f-5p improved cognitive function and reduced apoptosis and proliferation.
  • Deoxycytidinephosphate deaminase (Dctd) was identified as a direct target of miR-669f-5p; its overexpression reversed miR-669f-5p effects and ameliorated cognitive impairment.

Conclusions:

  • miR-669f-5p contributes to sevoflurane-induced cognitive impairment by targeting Dctd and activating the TLR2/4-MyD88-NF-κB pathway.
  • These findings highlight miR-669f-5p and the identified pathway as potential therapeutic targets for POCD.

Related Concept Videos